Heterogeneity of Extracellular Vesicles and Non‐Vesicular Nanoparticles in Glioblastoma
Tuoye Xu(Beth Israel Deaconess Medical Center), Al Charest(Beth Israel Deaconess Medical Center)
Cited by 3
Related Papers
Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression
|Nature Immunology|2022|290
ROS Fusion Tyrosine Kinase Activates a SH2 Domain–Containing Phosphatase-2/Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Signaling Axis to Form Glioblastoma in Mice
|Cancer Research|2006|166
A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine
|Nature Communications|2018|51